Keith R. Jerome, MD PhD

Professor
Fred Hutchinson Cancer Center
Seattle, Washington, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 689 - HHV-6 and EBV Reactivation after Allogeneic Hematopoietic Cell Transplantation in the Era of Letermovir for CMV Prophylaxis: A Retrospective Cohort Study

  Thursday, October 20, 2022
  12:15 PM – 12:45 PM US ET

• 789 - Viral and Immunologic biomarkers of COVID-19 improve risk stratification and identify patients most likely to benefit from therapy with remdesivir

  Thursday, October 20, 2022
  4:15 PM – 4:30 PM US ET